TKNO FY 2025 Earnings — Alpha Teknova, Inc. Revenue & Financial Results | Market Cap Arena

TKNOAlpha Teknova, Inc.

$133M

FY 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$41M+7.4% YoY

Gross Profit

$13M33.2% margin

Operating Income

-$17M-41.9% margin

Net Income

-$17M-42.6% margin

EPS (Diluted)

$-0.32

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$9M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$104M

Total Liabilities

$35M

Stockholders' Equity

$69M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$41M	$38M	+7.4%
Gross Profit	$13M	$7M	+85.9%
Operating Income	-$17M	-$26M	+35.1%
Net Income	-$17M	-$27M	+35.5%